Medtronic's advanced hybrid closed loop system — with the lowest commercial AID glucose target (100 mg/dL), every-5-minute auto-corrections, and Meal Detection that covers what you didn't bolus for. The system where Active Insulin Time is everything.
Device specifications change frequently — always verify current information directly with the manufacturer before making any decisions. Full disclaimer.
New to the 780G? Start here.
Scott spoke with Que Dallara — President & CEO of Medtronic's Diabetes operating unit — about the 780G, its sensor lineup, and the Medtronic MiniMed spinoff. Episode #1697 → juiceboxpodcast.com/episodes/jbp1697
The MiniMed 780G is Medtronic's advanced hybrid closed loop (AHCL) system — a tubed insulin pump that pairs with a Medtronic CGM and uses the SmartGuard algorithm to adjust insulin delivery automatically every 5 minutes. What sets it apart from other AID systems: it's the only commercial AID that can target 100 mg/dL, delivers auto-correction boluses continuously throughout the day (not just overnight), and has a Meal Detection feature that catches meals you forgot to bolus for. FDA cleared in the US in April 2023; available in Europe since June 2020.
Medtronic's clinical recommendation: use the 100 mg/dL target with a 2-hour Active Insulin Time (AIT) for highest TIR. This setting combination produces the strongest outcomes in both pivotal trials and real-world data.
What SmartGuard DoesSmartGuard continuously adjusts background insulin delivery based on your CGM reading and predicted glucose trend — increasing delivery when rising, reducing or suspending when falling. It uses your selected target and AIT to calculate the right amount.
When auto-basal adjustment isn't enough and glucose is above 120 mg/dL, SmartGuard delivers automatic correction boluses — up to every 5 minutes. This is continuous daytime and nighttime correction, not just overnight.
If you missed a meal bolus — or significantly underestimated your carbs — SmartGuard detects the rapid glucose rise and intensifies correction automatically. Real-world data shows the system can achieve 68% TIR in completely unannounced meals.
The algorithm predicts glucose 30 minutes ahead and reduces or stops insulin delivery proactively before a low occurs — not just in response to one. It also reviews each meal bolus for hypoglycemia risk over the next 4 hours and trims the dose if needed.
The 780G has the lowest glucose target available in any commercial AID system. At 100 mg/dL, it's genuinely trying to keep you in the same range a person without diabetes lives in — not just in the "acceptable" range.
— Juicebox Podcast Device Guide · jbp1697 with Que Dallara · juiceboxpodcast.com/episodes/jbp1697T1D, all ages. High-baseline HbA1c patients see largest gains (+23.3% TIR in lowest-TIR subgroup). Also indicated for patients with hypoglycemia unawareness — predictive suspend is a core feature.
DME benefit. Prior authorization typically required. 4-year pump warranty. MiniMed 770G users can upgrade via remote software update at no cost. Confirmed: Medtronic MiniMed spinoff in progress — watch for brand changes.
Adults: 100 mg/dL target, 2-hour AIT. Pediatric (≤15): start at 110 mg/dL, reduce to 100 if no hypoglycemia. AIT is the primary clinical tuning lever — shorter = more aggressive.
Pre-meal bolus 15–20 min before eating. Missed bolus within 30 min: deliver half the carb amount. After 30 min: correction bolus only if system recommends. Consistency in meal bolusing drives best outcomes.
Guardian 4 (7-day), Simplera Sync (disposable, 6-day), Instinct by Abbott (15-day, Medtronic/Abbott collaboration). Guardian 4 requires one calibration after 2-hour warmup. Acetaminophen causes false elevations.
Pivotal: TIR 74.5%, HbA1c 7.0%. With recommended settings: TIR 78.8%. Real-world (n=4,120): TIR 73.2%. Children ≤15 with recommended settings (n=3,543): TIR 78%.
The 780G is configured differently than most AID systems. Your basal rates matter less here — SmartGuard replaces them. The I:C ratio still matters for meal boluses. But the one setting that shapes everything about how the system behaves is Active Insulin Time (AIT). Understanding AIT is how you get from average results to excellent ones.
AIT tells the algorithm how long insulin remains active in your body. A shorter AIT = the system assumes insulin clears faster = it's more willing to deliver more insulin sooner. A longer AIT = assumes more IOB lingering = more conservative. Medtronic's recommended starting AIT: 2 hours.
Rather than adjusting basal rates and ISF individually (as in other systems), the 780G's primary tuning approach is AIT adjustment. If you're running consistently above target: try shortening AIT. If running low: lengthen it. Clinical guidance: keep TBR <4% before tightening further.
Pre-bolus 15–20 minutes before eating when possible. If you forgot: bolus for 50% of carbs within 30 minutes of the meal. After 30 minutes have passed, rely on the system's correction bolus recommendation instead. Don't skip boluses and expect SmartGuard to fully compensate — the outcomes are better with proper bolusing.
SmartGuard requires occasional user input to stay active — primarily entering BG values when prompted. If a required action isn't taken within the countdown window, the system exits to Manual Mode. A blue shield icon on the display indicates SmartGuard is active. Most pivotal trial participants spent >93% of time in SmartGuard.
Use the 100 mg/dL target with 2-hour AIT from the start if the patient has no significant hypoglycemia history. This is Medtronic's clinical recommendation and produces the best outcomes in evidence. Don't start conservative and stay there indefinitely.
Before tightening settings further, confirm TBR <4%. If TBR is above 4%, address lows before pursuing higher TIR. The algorithm is aggressive at recommended settings — ensure the foundation is safe before optimizing.
Pre-meal bolusing behavior is the biggest modifiable outcome driver. Patients who bolus consistently at every meal outperform those who rely on Meal Detection. Meal Detection is a safety net, not a strategy.
Guardian 4 sensor is sensitive to acetaminophen — false glucose elevations can drive excessive auto-corrections. Counsel patients to use ibuprofen (if appropriate) or inform the system before taking acetaminophen-containing medications.
TIR 74.5%, HbA1c 7.0% (from 7.5%), TBR reduced 3.3%→2.3%. N=82 adolescents & adults. No severe hypoglycemia or DKA reported.
TIR 78.8% ± 5.5%. Adults: 100 mg/dL, 2h AIT. Pediatric (≤15): start 110, reduce to 100. AIT is primary tuning lever.
Mean TIR 73.2%. Children ≤15 with recommended settings (n=3,543): 78% TIR. Lowest baseline subgroup: +23.3% TIR gain.
~68% TIR with completely unannounced meals — equivalent to announced meals in Manual Mode (Grosman et al., Diabetes Technol Ther 2024).
300-unit reservoir. 3-day standard or 7-day Extended infusion sets. Waterproof. CareLink web data. CareLink Connect caregiver app. MiniMed Mobile iOS/Android.
Guardian 4 (7-day, 1 calibration). Simplera Sync (6-day, factory-cal). Instinct by Abbott (15-day). All require separate CGM prescription.